Detailed price information for Ainos Inc (AIMD-Q) from The Globe and Mail including charting and trades.
("ASE") under the announced $2.1 million, three-year agreement.
Detailed price information for Ainos Inc (AIMD-Q) from The Globe and Mail including charting and trades.
Gainers DNA X (NASDAQ:SONM) stock increased by 14.7% to $4.14 during Thursday's pre-market session. The company's market cap stands at $5.3 million. Ainos (NASDAQ:AIMD) stock rose 13.35% to $1.58. The market
("BioPhoenix"), establishing a collaboration framework with a potential aggregate value of $10 million. The framework comprises an initial license fee, conditional consideration for licenses covering 15 additional indications, and a one-time fee upon the first sublicense.
Report points to front-end semiconductor orders, a $2.VASRO highlighted two developments that it views as important markers in Ainos' semiconductor commercialization: the transition of its front-end semiconductor program from validation to initial commercial orders, and the expansion of its proprietary real-world chemical dataset beyond 1 billion records.
Ainos Inc. (NASDAQ:AIMD) shares rose 6.
Ainos is receiving initial commercial orders from a front-end semiconductor company.The milestone marks Ainos' progress toward commercial adoption in front-end semiconductor environments and represents a step toward the broader revenue-generation opportunities the Company is pursuing.
New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world applicationsHOUSTON, TX / ACCESS Newswire / September 9, 2026 / (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has secured three new Japanese patents covering AI Nose technologies and their integration with robotic systems.AI Is Moving Into the Physical World - and Machines Nee
This is the newest page. Registered accounts read further back.